Fear in US as drug shortages mount

September 4, 2011 by Jean-Louis Santini

Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.

A recent report by the (FDA) found that the number of important treatments that are difficult or impossible to find nearly tripled from 61 to 178 between 2005 and 2010.

Most of the rare medications are for hospital use, including sterile injections, intravenous treatments, and antibiotics. The products include both name-brand and generic drugs.

"FDA hears from patients and also from and organizations about the terrible impact the shortages have had," spokeswoman Shelly Burgess said.

"We continue to do all we can under our current authority to address shortages when they occur."

The FDA's efforts are hindered, however, because it cannot force private to produce certain drugs or even require them to notify the agency when they plan to discontinue one, Burgess said.

In 2010 it was able to avert 38 shortages, mainly by persuading other manufacturers to produce the drugs or helping to resolve production issues.

But a survey of 820 hospitals carried out in June by the American Hospital Association found that almost all had run out of an important drug over the past six months.

Eighty-percent said they had to delay patient treatments because of scarcity, and 70 percent said they administered less effective treatments.

"We really need to take a very careful look at what is going on. I have never seen anything like this and I have been a for over 40 years," says Mike Cohen, a pharmacist at the non-profit Safe .

The group recently surveyed 1,800 and found that a third of doctors and a fifth of pharmacists were aware of adverse reactions in their patients -- including deaths -- because of .

Cynthia Reilly of the American Society of Health System Pharmacists says the "dramatic increase" in shortages is in part due to "quality issues."

"In a lot of instances the manufacturer is either having problems with the production lines or perhaps they found particular products in vials so they have to do a recall," she said.

Reilly fears the shortages will worsen as the pharmaceutical industry continues to consolidate, and as more companies stop producing because they are less profitable.

"A few years ago five companies were making a similar product. Now there is only one or two... There are not a lot of companies to fill the gap," she said.

She and other advocates believe new legislation to allow the FDA to force companies to alert it six months in advance of closing a production line would be helpful, as it would give the agency more time to find a substitute.

Two bills with broad support are currently under discussion in Congress.

Another problem is the so-called "gray market," whereby distributors scoop up rare drugs and then charge hospitals exorbitant rates for them. Some drugs can fetch up to 1,000 times the normal price.

"We tell our members to contact their state attorney general. Unfortunately there is opportunity for unscrupulous behavior," Reilly said.

Explore further: US drug supplies run short, endangering patients

Related Stories

US drug supplies run short, endangering patients

August 19, 2011
Monika McBride has acute myeloid leukemia, a life-threatening blood cancer that requires six months of intensive chemotherapy. Three days before her third treatment, however, a nurse called to cancel her appointment: Her ...

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Vendicar_Decarian
4.3 / 5 (4) Sep 04, 2011
Bush accused of pressuring countries to stop producing generic drugs

http://www.ncbi.n...C487728/

Bush Signed Law Blocking Generic Drug

Campaign: Texas was one of just three states to make it harder for doctors to prescribe cheaper blood-thinner.

http://articles.l...mn-38364

douglaskostyk
5 / 5 (1) Sep 04, 2011
frajo
5 / 5 (2) Sep 06, 2011
A definite failure of the Free Market model.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.